Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0B5MZ
|
||||
| Former ID |
DNC004612
|
||||
| Drug Name |
3-(4-Amino-phenyl)-3-butyl-piperidine-2,6-dione
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [533478] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C15H20N2O2
|
||||
| Canonical SMILES |
CCCCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N
|
||||
| InChI |
1S/C15H20N2O2/c1-2-3-9-15(10-8-13(18)17-14(15)19)11-4-6-12(16)7-5-11/h4-7H,2-3,8-10,16H2,1H3,(H,17,18,19)
|
||||
| InChIKey |
HECRHMWBGLSDHM-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cytochrome P450 11A1, mitochondrial | Target Info | Inhibitor | [533478] | |
| Cytochrome P450 19 | Target Info | Inhibitor | [533478] | ||
| NetPath Pathway | FSH Signaling PathwayNetPath_25:FSH Signaling Pathway | ||||
| PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
| PathWhiz Pathway | SteroidogenesisPW000045:Androgen and Estrogen Metabolism | ||||
| WikiPathways | Prostaglandin Synthesis and Regulation | ||||
| Metapathway biotransformation | |||||
| Oxidation by Cytochrome P450 | |||||
| Metabolism of steroid hormones and vitamin D | |||||
| Glucocorticoid & Mineralcorticoid Metabolism | |||||
| Corticotropin-releasing hormone | |||||
| Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
| Tryptophan metabolism | |||||
| Ovarian Infertility Genes | |||||
| FSH signaling pathway | |||||
| Integrated Breast Cancer Pathway | |||||
| Phase 1 - Functionalization of compounds | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.